Home > Result Summaries: Compounds > Combined Diphtheria, Tetanus, Acellular Pertussis Adsorbed, Hepatitis B (Recombinant), Inactivated Polio Vaccine > Result Summary for 217744/028

Result Summary for 217744/028

Result Summary

Protocol ID:	217744/028
Clinical Study ID:	217744/028 (DTPa-HBV-IPV-028)
Official Title:	Study to assess the safety and reactogenicity of SB Bios DTPa vaccine, co-administered with commercial Hib vaccine as compared to SB Bios' DTPa vaccine-SB Bios' DTPa-IPV vaccine each time mixed with SB Bios’ Hib vaccine, and to SB Bios’ DTPa-HBV-IPV vaccine co-administered with SB Bios’ Hib vaccine
Phase:	Phase 3
Study Indications or Diseases:	Diphtheria-Tetanus-aPertussis-Hepatitis B-Poliomyelitis Vaccines
Generic Name:	Combined Diphtheria, Tetanus, Acellular Pertussis Adsorbed, Hepatitis B (Recombinant), Inactivated Polio Vaccine
Trade/Product Name:	Pediarix;Infanrix_penta
Approved Drug Label:	http://www.gsk.com/products.html
Results Summary:	Click here to download result summary.
Citations:	Zepp F, et al. A combined DTPa-HBV-IPV for use (as a fourth dose) in the second year of life. PROC 37th ANNU MEET INFECT DIS SOC AMERICA (IDSA) PHILADELPHIA. 1999; 155.